Sterling Investment Advisors (Pennsylvania)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Buy
1,200
+100
+9% +$56.1K 0.11% 130
2026
Q1
$618K Hold
1,100
0.11% 124
2025
Q4
$744K Hold
1,100
0.14% 118
2025
Q3
$703K Hold
1,100
0.14% 115
2025
Q2
$590K Hold
1,100
0.13% 119
2025
Q1
$462K Hold
1,100
0.11% 124
2024
Q4
$455K Buy
+1,100
New +$482K 0.11% 114
2018
Q3
Sell
-500
Closed -$108K 429
2018
Q2
$108K Hold
500
0.06% 139
2018
Q1
$96K Buy
+500
New +$92.3K 0.06% 145

Other funds holding IDXX

Sterling Investment Advisors (Pennsylvania)'s IDXX Position: Q2 2026 in Review

Sterling Investment Advisors (Pennsylvania) increased its Idexx Laboratories (IDXX) stake by 9.1% in Q2 2026, buying an estimated $56.1K and bringing the position to 1,200 shares worth $632K. The position accounts for 0.11% of the portfolio, ranked #130.

Sterling Investment Advisors (Pennsylvania) first reported a position in IDXX in Q1 2018 and has held it in 9 quarters since. The position peaked at $744K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sterling Investment Advisors (Pennsylvania) held 1,200 shares of Idexx Laboratories worth $632K as of Q2 2026.
  • Sterling Investment Advisors (Pennsylvania) bought 100 Idexx Laboratories shares in Q2 2026, an estimated $56.1K.
  • Idexx Laboratories made up 0.11% of Sterling Investment Advisors (Pennsylvania)'s portfolio in Q2 2026, its #130 holding.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Idexx Laboratories in Q1 2018 and has held it in 9 quarters since.
  • Sterling Investment Advisors (Pennsylvania)'s Idexx Laboratories position peaked at $744K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 28 Jul 2026.